Medulloblastoma, a brain cancer found in children, is known to have an upregulation of the PI3K pathway, and when treated with pictilisib (GDC-0941), a PI3K class 1 selective inhibitor, cell migration and tumor growth is impaired [16]. Here, PIK3CB is linked to medulloblastoma.